Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EuroPainClinics Study II: Epiduroscopy in FBSS
NCT02459392Completed
- Sponsor
- EuroPainClinics
- Start
- Dec 2021
- Primary completion
- Dec 2021
- Modality
- Therapeutic Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of hyaluronidase and methylprednisolone in failed back surgery syndrome (FBSS) (4 arms), sponsored by EuroPainClinics. Primary endpoint: Pain as assessed by the Visual analogue scale at 3 years. Started Dec 2021; status: completed.
02
Drugs
hyaluronidasemethylprednisolone
03
Conditions
failed back surgery syndrome (FBSS)
Beyond the preview
Go deeper on NCT02459392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02459392.